Evidence map›Paper›PMID 27486020›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016

Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.

Susan T Vadaparampil, Teri L Malo, Steven K Sutton, Karla N Ali, Jessica A Kahn, Alix Casler, Daniel Salmon, Barbara Walkosz, Richard G Roetzheim, Gregory D Zimet and 1 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2024
    Pooled it
  2. Disparities in Healthcare Providers' Recommendation of HPV Vaccination for U.S. Adolescents: A Systematic Review.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Susan T VadaparampilDivision of Population Science, Moffitt Cancer Center, Tampa, Florida. Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida. Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, Florida. Susan.Vadaparampil@Moffitt.org.
Teri L MaloLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Steven K SuttonDivision of Population Science, Moffitt Cancer Center, Tampa, Florida. Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, Florida.
Karla N AliDivision of Population Science, Moffitt Cancer Center, Tampa, Florida.
Jessica A KahnDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohia.
Alix CaslerDepartment of Pediatrics, Orlando Health Physician Associates, Orlando, Florida.
Daniel SalmonDepartment of International Health and Health Behavior Society, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Barbara WalkoszKlein Buendel, Boulder, Colorado.
Richard G RoetzheimDivision of Population Science, Moffitt Cancer Center, Tampa, Florida. Department of Family Medicine, College of Medicine, University of South Florida, Tampa, Florida.
Gregory D ZimetDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.
Anna R GiulianoDivision of Population Science, Moffitt Cancer Center, Tampa, Florida. Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, Florida. Department of Oncologic Sciences, College of Medicine, University of South Florida, Tampa, Florida.

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
LINEBERGER CANCER CONTROL EDUCATION PROGRAMR25CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EARP, JO ANNE L, RIBISL, KURT M. · 1992 to 2016
$8.0M
Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
NCI NIH HHS P30 CA076292NCI NIH HHS R25 CA057726NCI NIH HHS T32 CA057726
6 · The paper itself

Abstract

backgroundRates of routine human papillomavirus (HPV) vaccination of adolescent males in the United States are low. Leading health organizations advocate consistent and strong physician recommendations to improve HPV vaccine dissemination. This study describes the prevalence and correlates of consistent and strong physician recommendations for HPV vaccination of adolescent males.

methodsWe surveyed pediatric and family medicine physicians in Florida about their HPV vaccine recommendations for male vaccine-eligible age groups (11-12, 13-17, 18-21 years). Descriptive statistics compared consistency and strength of HPV recommendations across age groups. Multivariable logistic regression examined factors associated with consistent and strong recommendations for 11- to 12-year-olds.

resultsWe received 367 completed surveys (51% response rate). Physicians most often consistently and strongly recommended HPV vaccine to males ages 13 to 17 (39%) compared with ages 11 to 12 (31%) and 18 to 21 (31%). Consistent and strong recommendation for 11- to 12-year-old males was more likely to be delivered by Vaccine for Children providers and less likely among physicians who reported more personal barriers to vaccination, particularly concerns about vaccine safety, concerns about adding vaccines to the vaccine schedule, and difficulty in remembering to discuss HPV vaccination.

conclusionsPhysicians' current consistency and strength of HPV vaccine recommendations do not align with national recommendations. Interventions to improve HPV vaccine recommendations must also consider the influence of physicians' personal barriers to HPV vaccine delivery. IMPACT: As one of the first studies to examine both consistency and strength of physicians' HPV vaccine recommendations for males, our findings can inform future interventions focused on facilitating physicians' recommendations. Cancer Epidemiol Biomarkers Prev; 25(10); 1435-46. ©2016 AACR.

Indexed as

Health Knowledge, Attitudes, PracticePapillomavirus VaccinesAdolescentAdultChildFemaleGuideline AdherenceHumansMaleMiddle AgedPractice Patterns, Physicians'Surveys and QuestionnairesUnited StatesVaccinationYoung AdultPapillomavirus Vaccines

Identifiers

PMID27486020
PMCPMC5050120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.